Prehospital HMG Co-A Reductase Inhibitor Use and Reduced Mortality in Ruptured Abdominal Aortic Aneurysm

被引:14
|
作者
Feeney, James M. [1 ,3 ]
Burns, Karyl [1 ,3 ]
Staff, Ilene [2 ]
Bai, Jilin [3 ]
Rodrigues, Natercia [3 ]
Fortier, Jill [3 ]
Jacobs, Lenworth M. [1 ,3 ]
机构
[1] Hartford Hosp, Dept Traumatol & Emergency Med, Hartford, CT 06102 USA
[2] Hartford Hosp, Dept Res Adm, Hartford, CT 06102 USA
[3] Univ Connecticut, Sch Med, Farmington, CT USA
关键词
ENDOTHELIAL NITRIC-OXIDE; SMOOTH-MUSCLE-CELLS; STATIN THERAPY; SIMVASTATIN; SHOCK; INFLAMMATION; ACTIVATION; CAVEOLIN; SURVIVAL; SEPSIS;
D O I
10.1016/j.jamcollsurg.2009.03.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The compounds 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (HMG Co-A reductase inhibitors, statins) are popular medications for the control of elevated serum cholesterol. Recent evidence has demonstrated a survival benefit to patients who take statins in the premorbid period with severe sepsis, septic shock, or severe trauma. We hypothesized that a similar benefit Would be seen in patients with ruptured abdominal aortic aneurysm. STUDY DESIGN: We completed a retrospective review of patients with ruptured abdominal aortic aneurysm in our institution from January 2000 to December 2008. We compared age, gender, mortality rates, and Physiologic and Operative Severity Score for the enumeration of Mortality and Morbidity (POSSUM) scores for all patients who met inclusion and exclusion criteria. We compared hospital and ICU lengths of stay, cardiac morbidity and number of cardiac events per patient between survivor groups with and without prehospital statin use. We compared mortality, cardiac morbidity, and gender using the Pearson chi-square test, Physiologic and Operative Severity Score for the enumeration of Mortality and Morbidity scores and age using the Student's t-test and lengths of stay using the Mann Whitney-U test. RESULTS: Mortality in the group without prehospital statin use was 63.8%, and in the group with prehospital statin use was 34.8% (p = 0.018, odds ratio 0.30 to 0.11). Physiologic and Operative Severity Score for the enumeration of Mortality and Morbidity scores were similar between survivor groups with and without statin use and nonsurvivor groups with and without statin use. Hospital and ICU lengths of stay, cardiac morbidity, and number of cardiac events per patient were not statistically different among survivors. CONCLUSIONS: Prehospital statin use appears to be associated with a significant survival benefit in the ruptured abdominal aortic aneurysm population. (J Am Coll Surg 2009;209:41-46. (C) 2009 by the American College of Surgeons)
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [1] Prehospital HMG Co-A reductase inhibitor use and reduced mortality in hemorrhagic shock due to trauma
    J. M. Feeney
    V. Jayaraman
    J. Spilka
    D. S. Shapiro
    S. Ellner
    W. T. Marshall
    L. M. Jacobs
    [J]. European Journal of Trauma and Emergency Surgery, 2012, 38 : 171 - 176
  • [2] Prehospital HMG Co-A reductase inhibitor use and reduced mortality in hemorrhagic shock due to trauma
    Feeney, J. M.
    Jayaraman, V.
    Spilka, J.
    Shapiro, D. S.
    Ellner, S.
    Marshall, W. T., III
    Jacobs, L. M.
    [J]. EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2012, 38 (02) : 171 - 176
  • [3] Mortality of ruptured abdominal aortic aneurysm with selective use of endovascular repair
    Verhoeven, E. L. G.
    Kapma, M. R.
    Bos, W. T. G. J.
    Vourliotakis, G.
    Bracale, U. M.
    Bekkema, F.
    Vahl, A. C.
    Van den Dungen, J. J. A. M.
    [J]. JOURNAL OF CARDIOVASCULAR SURGERY, 2009, 50 (05): : 587 - 593
  • [4] Mortality from ruptured abdominal aortic aneurysm in Wales
    Basnyat, PS
    Biffin, AHB
    Moseley, LG
    Hedges, AR
    Lewis, MH
    [J]. BRITISH JOURNAL OF SURGERY, 1999, 86 (06) : 765 - 770
  • [5] Mortality Risk for Ruptured Abdominal Aortic Aneurysm in Women
    De Rango, Paola
    Simonte, Gioele
    Manzone, Alessandra
    Farchioni, Luca
    Cieri, Enrico
    Verzini, Fabio
    Parlani, Gianbattista
    Isernia, Giacomo
    Lenti, Massimo
    [J]. ANNALS OF VASCULAR SURGERY, 2017, 39 : 143 - 151
  • [6] In-hospital mortality of ruptured abdominal aortic aneurysm
    Grant, Mark W.
    Thomson, Ian A.
    van Rij, Andre M.
    [J]. ANZ JOURNAL OF SURGERY, 2008, 78 (08) : 698 - 704
  • [7] Cerivastatin, a new synthetic HMG CO-A reductase inhibitor in the treatment of patients with primary hyperlipidaemia
    Kukharchuk, VV
    Solovieva, EY
    Rozhkova, TA
    Tvorogova, MG
    [J]. ATHEROSCLEROSIS, 1999, 144 : 196 - 197
  • [8] Mortality After Hospital Admission for Ruptured Abdominal Aortic Aneurysm
    Schloesser, Felix J. V.
    Vaartjes, Ilonca
    van der Heijden, Geert J. M. G.
    Moll, Frans L.
    Verhagen, Hence J. M.
    Muhs, Bart E.
    de Borst, Gert J.
    Groenestege, Andreas T. Tiel
    Kardaun, Jan W. P. F.
    Reitsma, Johannes B.
    van der Graaf, Yolanda
    Bots, Michiel L.
    [J]. ANNALS OF VASCULAR SURGERY, 2010, 24 (08) : 1125 - 1132
  • [9] Mortality from ruptured abdominal aortic aneurysm in Wales - Reply
    Basnyat, PS
    Biffin, AHB
    Moseley, LG
    Hedges, AR
    Lewis, ME
    [J]. BRITISH JOURNAL OF SURGERY, 2000, 87 (07) : 966 - 967
  • [10] Interfacility transfer and mortality for patients with ruptured abdominal aortic aneurysm
    Mell, Matthew W.
    Wang, Nancy E.
    Morrison, Doug E.
    Hernandez-Boussard, Tina
    [J]. JOURNAL OF VASCULAR SURGERY, 2014, 60 (03) : 553 - 557